Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hans-Ulrich Hockey"'
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
Introduction Persistent hypercapnic failure in chronic obstructive pulmonary disease (COPD) is associated with poor prognosis. Long-term home non-invasive ventilation is recommended for patients with PaCO2 >7.0 kPa. Domiciliary high-flow nasal cannul
Externí odkaz:
https://doaj.org/article/1ca74b40088245689587162e104c285d
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease.
Milne RJ, Hockey HU, Garrett J. Int J Chron Obstruct Pulmon Dis. 2022;17:1311-1322. On page 1311: there was an error in the Results section in the Abstract where some text was transposed. The authors apologize for the error. The correct text for the
Autor:
Benjamin A Fisher, Michele Bombardieri, Hans-Ulrich Hockey, Antónia Szántó, Andrew M Wright, Athena Papas, Michael Rotte, Alexandre Avrameas, David A. Isenberg, Bettina Bannert, Pascal Espie, Cyrielle Dupuy, Steven E. Carsons, Diego Kyburz, Maximilian G. Posch, Marie-Anne Valentin, Julie Milojevic, Francesca Barone, Petra M Faerber, Simon J Bowman, Arwa M. Farag, Thomas Daikeler, Xiaohui Ren, Peter Gergely, David Floch, Wan-Fai Ng, James S. Rush, Alan Kivitz
Publikováno v:
The Lancet Rheumatology. 2:e142-e152
Summary Background Primary Sjogren's syndrome is an autoimmune disease that presents as dryness of the mouth and eyes due to impairment of the exocrine glands. To our knowledge, no systemic therapies for primary Sjogren's syndrome have shown efficacy
Publikováno v:
International journal of chronic obstructive pulmonary disease. 17
Richard J Milne,1,2 Hans-Ulrich Hockey,3 Jeffrey Garrett4 1Health Outcomes Associates Ltd, Auckland, New Zealand; 2School of Pharmacy, University of Auckland, Auckland, New Zealand; 3Biometrics Matters Ltd, Hamilton, New Zealand; 4Middlemore Hospital
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Storgaard, L H, Hockey, H-U, Laursen, B S & Weinreich, U M 2018, ' Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure ', International Journal of Chronic Obstructive Pulmonary Disease, vol. 13, pp. 1195-1205 . https://doi.org/10.2147/COPD.S159666
Storgaard, L H, Hockey, H-U, Laursen, B S & Weinreich, U M 2018, ' Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure ', International Journal of Chronic Obstructive Pulmonary Disease, vol. 13, pp. 1195-1205 . https://doi.org/10.2147/COPD.S159666
Line Hust Storgaard,1 Hans-Ulrich Hockey,2 Birgitte Schantz Laursen,3,4 Ulla Møller Weinreich1,3 1Department of Respiratory Diseases, Aalborg University Hospital, Aalborg, Denmark; 2Biometrics Matters Limited, Hamilton, New Zealand; 3Department of C
Publikováno v:
Storgaard, L H, Hockey, H-U & Weinreich, U M 2020, ' Development in PaCO 2 over 12 months in patients with COPD with persistent hypercapnic respiratory failure treated with high-flow nasal cannula-post-hoc analysis from a randomised controlled trial ', BMJ open respiratory research, vol. 7, no. 1, e000712 . https://doi.org/10.1136/bmjresp-2020-000712
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
BMJ Open Respiratory Research
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
BMJ Open Respiratory Research
IntroductionPersistent hypercapnic failure in chronic obstructive pulmonary disease (COPD) is associated with poor prognosis. Long-term home non-invasive ventilation is recommended for patients with PaCO2 >7.0 kPa. Domiciliary high-flow nasal cannula
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia
Autor:
Baltazar Gomez-Mancilla, Jean-Christophe Corvol, Gurutz Linazasoro, Izabela Rozenberg, Karla Eggert, Alberto J. Espay, Daniela Berg, Christian Geny, Pascal Derkinderen, Judit Sovago, Johannes Schwarz, Fabrizio Stocchi, Franck Durif, Andrew Feigin, Dominik Feuerbach, Jean-Luc Houeto, Thérèse Di Paolo, Claudia Trenkwalder, Judith Jaeger, Andres O. Ceballos-Baumann, Lin Zhang, Paul Maruff, Markus Weiss, Christine Tranchant, Donald Johns, Alexander Storch, Emmanuel Broussolle, Annamaria Jakab, Hans Ulrich Hockey, Olivier Rascol, Jean-Philippe Azulay, Luc Defebvre, Michal Gostkowski
Publikováno v:
Movement Disorders. 31:1049-1054
Background This phase 2 randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of the nicotinic acetylcholine receptor α7 agonist AQW051 in patients with Parkinson's disease and levodopa-induced dyskinesia. Methods Pati
Publikováno v:
Cornea
Objective: To evaluate whether inhibition of the pro-inflammatory cytokines IL-1β or IL-17A by canakinumab or secukinumab, respectively, influence the signs and symptoms of dry eye. Design: A double-masked, placebo-controlled, outpatient clinical tr
Autor:
Alan Kivitz, Xiaohui Ren, Steven E. Carsons, Michele Bombardieri, Pierre Moulin, Wan-Fai Ng, Arwa M. Farag, James S. Rush, Peter Gergely, David A. Isenberg, Bettina Bannert, Margit Zeher, Pascal Espie, Thomas Daikeler, Petra M Faerber, Athena Papas, Francesca Barone, Andrew M Wright, Michael Rotte, Benjamin A Fisher, Hans Ulrich Hockey, Simon J. Bowman, Grazyna Wieczorek, Maximilian G. Posch, David Floch, Cyrielle Dupuy
Publikováno v:
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 126:e203-e204
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia
Autor:
Claudia, Trenkwalder, Daniela, Berg, Olivier, Rascol, Karla, Eggert, Andres, Ceballos-Baumann, Jean-Christophe, Corvol, Alexander, Storch, Lin, Zhang, Jean-Philippe, Azulay, Emmanuel, Broussolle, Luc, Defebvre, Christian, Geny, Michal, Gostkowski, Fabrizio, Stocchi, Christine, Tranchant, Pascal, Derkinderen, Franck, Durif, Alberto J, Espay, Andrew, Feigin, Jean-Luc, Houeto, Johannes, Schwarz, Thérèse, Di Paolo, Dominik, Feuerbach, Hans-Ulrich, Hockey, Judith, Jaeger, Annamaria, Jakab, Donald, Johns, Gurutz, Linazasoro, Paul, Maruff, Izabela, Rozenberg, Judit, Sovago, Markus, Weiss, Baltazar, Gomez-Mancilla
Publikováno v:
Movement disorders 31(7), 1049-1054 (2016). doi:10.1002/mds.26569
This phase 2 randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of the nicotinic acetylcholine receptor α7 agonist AQW051 in patients with Parkinson's disease and levodopa-induced dyskinesia.Patients with idiopathic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::87d8f8277e4711a4fd7b611116e0b789
https://pub.dzne.de/record/138662
https://pub.dzne.de/record/138662